Product Name

  • Name

    2-(chloromethyl)-4-methylquinazoline

  • EINECS 1308068-626-2
  • CAS No. 109113-72-6
  • Article Data9
  • CAS DataBase
  • Density 1.251 g/cm3
  • Solubility 3.11g/L at 20℃
  • Melting Point 61 - 63 °C
  • Formula C10H9ClN2
  • Boiling Point 240.039 °C at 760 mmHg
  • Molecular Weight 192.648
  • Flash Point 122.14 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 109113-72-6 (2-(chloromethyl)-4-methylquinazoline)
  • Hazard Symbols
  • Synonyms MFCD09807547;NSC 48971;2-Amino-3,4-dimethylbenzoic acid;2-(Chloromethyl)-4-methylquinazoline;
  • PSA 25.78000
  • LogP 2.67700

Synthetic route

2-aminoacetophenone
551-93-9

2-aminoacetophenone

Chloroacetamide
79-07-2

Chloroacetamide

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

Conditions
ConditionsYield
Stage #1: 2-aminoacetophenone With phosphoric acid In ethanol at 20℃;
Stage #2: Chloroacetamide In ethanol Reagent/catalyst; Solvent; Reflux;
94.26%
With oxygen; triethylamine; copper(l) chloride In tetrahydrofuran for 12h; Reflux;88%
2-aminoacetophenone
551-93-9

2-aminoacetophenone

chloroacetonitrile
107-14-2

chloroacetonitrile

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane at 6℃; for 2h;85%
With hydrogenchloride; [1-(3-sulfonic acid)]propyl-3-methylimidazolium hydrogen sulfate In 1,4-dioxane; water at 8℃; for 18h; Reagent/catalyst; Temperature;85.14%
Stage #1: 2-aminoacetophenone With hydrogenchloride In 1,4-dioxane at 10℃; Cooling;
Stage #2: chloroacetonitrile In 1,4-dioxane at -10℃; for 1h;
45%
chloroacetonitrile
107-14-2

chloroacetonitrile

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

Conditions
ConditionsYield
Stage #1: 2-aminoacetophenone With hydrogenchloride In 1,4-dioxane at -10 - 25℃;
Stage #2: chloroacetonitrile In 1,4-dioxane at -10 - 2℃; for 3h;
Stage #3: With sodium hydroxide In 1,4-dioxane; water at 5 - 11℃;
74%
2-(chloromethyl)-4-methylquinazoline 3-oxide
6640-59-1

2-(chloromethyl)-4-methylquinazoline 3-oxide

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

Conditions
ConditionsYield
With phosphorus trichloride In chloroform Heating / reflux;57%
Ro 5-3663
70656-87-0

Ro 5-3663

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

Conditions
ConditionsYield
With trichlorophosphate for 0.5h; Heating;52%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione
853029-57-9

2-bromo-1-(but-2-ynyl)-4-methyl-6-((4-methylquinazolin-2-yl)methyl)-1H-imidazo[4,5-b]pyridine-5,7-(4H,6H)-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 90℃; for 8h;95.77%
With potassium carbonate In 1-methyl-pyrrolidin-2-one at 75℃; for 6h;93%
With sodium carbonate In N,N-dimethyl acetamide at 100℃; for 6h; Temperature; Large scale;89.4%
(R)-piperidin-3-ylcarbamic acid tert-butyl ester
309956-78-3

(R)-piperidin-3-ylcarbamic acid tert-butyl ester

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; 2-chloromethyl-4-methylquinazoline With potassium carbonate In 1-methyl-pyrrolidin-2-one; acetonitrile at 50℃; for 6h;
Stage #2: (R)-piperidin-3-ylcarbamic acid tert-butyl ester In 1-methyl-pyrrolidin-2-one; acetonitrile at 60℃; for 8h; Solvent; Temperature;
95.1%
With sodium carbonate at 55 - 60℃; for 6h; Concentration; Reagent/catalyst;91.8%
Stage #1: (R)-piperidin-3-ylcarbamic acid tert-butyl ester; 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione With 1-methyl-pyrrolidin-2-one; potassium carbonate; potassium iodide for 10h;
Stage #2: 2-chloromethyl-4-methylquinazoline for 12h; Time;
90%
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; 2-chloromethyl-4-methylquinazoline With potassium carbonate; potassium iodide In 1-methyl-pyrrolidin-2-one at 40 - 50℃;
Stage #2: (R)-piperidin-3-ylcarbamic acid tert-butyl ester Reagent/catalyst; Solvent; Temperature;
86.7%
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; 2-chloromethyl-4-methylquinazoline With potassium carbonate; potassium iodide In 1-methyl-pyrrolidin-2-one at 40 - 50℃;
Stage #2: (R)-piperidin-3-ylcarbamic acid tert-butyl ester In 1-methyl-pyrrolidin-2-one Reagent/catalyst; Solvent; Temperature;
8-[(R)-3-aminopiperidin-1-yl]-3,7-dihydro-3-methyl-7-(2-butynyl)-1H-purine-2,6-dione

8-[(R)-3-aminopiperidin-1-yl]-3,7-dihydro-3-methyl-7-(2-butynyl)-1H-purine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

Linagliptin

Linagliptin

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 10h;94.8%
With sodium hydrogencarbonate In 1-methyl-pyrrolidin-2-one at 90℃; Solvent; Temperature;1.8 g
2-bromo-3-(2-butyn-1-yl)-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one
705280-62-2

2-bromo-3-(2-butyn-1-yl)-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

2-bromo-3-(2-butyn-1-yl)-5-[(4-methyl-quinazolin-2-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one
705280-63-3

2-bromo-3-(2-butyn-1-yl)-5-[(4-methyl-quinazolin-2-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one

Conditions
ConditionsYield
With caesium carbonate In DMF (N,N-dimethyl-formamide) at 80℃; for 1h;94%
With caesium carbonate In DMF (N,N-dimethyl-formamide) at 80℃; for 1h;94%
With potassium carbonate In 1-methyl-pyrrolidin-2-one at 80℃; for 3h;75%
1-methyluracil
615-77-0

1-methyluracil

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

C15H14N4O2

C15H14N4O2

Conditions
ConditionsYield
With triethylamine In 1-methyl-pyrrolidin-2-one at 80 - 85℃; Reagent/catalyst; Solvent; Temperature;93.6%
With triethylamine In 1-methyl-pyrrolidin-2-one at 80 - 85℃; for 34h; Solvent; Temperature; Reagent/catalyst;93.6%
8-iodine-7-(2-butynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione

8-iodine-7-(2-butynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

7-but-2-ynyl-8-iodo-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione

7-but-2-ynyl-8-iodo-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 90℃; for 8h;93.2%
Stage #1: 8-iodine-7-(2-butynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione; 2-chloromethyl-4-methylquinazoline With sodium carbonate In 1-methyl-pyrrolidin-2-one at 90℃; for 11h;
Stage #2: With acetic acid In ethanol at 60℃; for 0.5h;
65%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

C13H14N2O2
886588-61-0

C13H14N2O2

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione
886588-63-2

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; C13H14N2O2 With 1-methyl-pyrrolidin-2-one; potassium carbonate; potassium iodide at 50 - 60℃;
Stage #2: 2-chloromethyl-4-methylquinazoline
91%
1-(but-2-yn-1-yl)-6-chloropyrimidine-2,4(1H,3H)-dione
1431528-74-3

1-(but-2-yn-1-yl)-6-chloropyrimidine-2,4(1H,3H)-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

1-(2-butyn-1-yl)-6-chloro-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4 (1H,3H)-dione

1-(2-butyn-1-yl)-6-chloro-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4 (1H,3H)-dione

Conditions
ConditionsYield
Stage #1: 1-(but-2-yn-1-yl)-6-chloropyrimidine-2,4(1H,3H)-dione With sodium hydride; lithium bromide In N,N-dimethyl-formamide at 0℃; for 0.5h; Inert atmosphere;
Stage #2: 2-chloromethyl-4-methylquinazoline In N,N-dimethyl-formamide at 80℃; Inert atmosphere;
88%
Stage #1: 1-(but-2-yn-1-yl)-6-chloropyrimidine-2,4(1H,3H)-dione With sodium hydride In dimethyl sulfoxide; N,N-dimethyl-formamide at 0℃; for 0.0833333h;
Stage #2: With lithium bromide In dimethyl sulfoxide; N,N-dimethyl-formamide for 0.25h;
Stage #3: 2-chloromethyl-4-methylquinazoline In dimethyl sulfoxide; N,N-dimethyl-formamide at 20℃;
86.5%
1-(but-2-yn-1-yl)-6-chloropyrimidine-2,4(1H,3H)-dione
1431528-74-3

1-(but-2-yn-1-yl)-6-chloropyrimidine-2,4(1H,3H)-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

1-methyl-6-chloro-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4(1H,3H)-dione

1-methyl-6-chloro-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
Stage #1: 1-(but-2-yn-1-yl)-6-chloropyrimidine-2,4(1H,3H)-dione With sodium hydride In dimethyl sulfoxide; N,N-dimethyl-formamide at 0℃; for 0.0833333h;
Stage #2: With lithium bromide In dimethyl sulfoxide; N,N-dimethyl-formamide for 0.25h;
Stage #3: 2-chloromethyl-4-methylquinazoline In dimethyl sulfoxide; N,N-dimethyl-formamide at 20℃;
86.5%
8-bromo-3-methyl-7-(thietan-3-yl)-3,7-dihydro-1H-pyrine-2,6-dione
1005482-51-8

8-bromo-3-methyl-7-(thietan-3-yl)-3,7-dihydro-1H-pyrine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

C19H17BrN6O2S

C19H17BrN6O2S

Conditions
ConditionsYield
Stage #1: 8-bromo-3-methyl-7-(thietan-3-yl)-3,7-dihydro-1H-pyrine-2,6-dione With potassium hydroxide In water; N,N-dimethyl-formamide for 0.5h;
Stage #2: 2-chloromethyl-4-methylquinazoline In water; N,N-dimethyl-formamide at 20℃; for 6h;
86%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

(R)-ethyl nipecotate
25137-01-3

(R)-ethyl nipecotate

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

C28H31N7O4

C28H31N7O4

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; (R)-ethyl nipecotate With 1-methyl-pyrrolidin-2-one; potassium carbonate; potassium iodide at 60 - 70℃;
Stage #2: 2-chloromethyl-4-methylquinazoline
85%
3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)piperidin-1-yl]xanthine
666816-91-7

3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)piperidin-1-yl]xanthine

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine

1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In cyclohexane Reagent/catalyst; Solvent; Reflux;80.3%
8-bromo-3-methyl-7-(prop-2-ynyl)-1H-purine-2,6(3H,7H)-dione

8-bromo-3-methyl-7-(prop-2-ynyl)-1H-purine-2,6(3H,7H)-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

8-bromo-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-7-(prop-2-ynyl)-1H-purine-2,6(3H,7H)-dione

8-bromo-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-7-(prop-2-ynyl)-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
With sodium carbonate In N,N-dimethyl-formamide at 80℃; for 12h;80%

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

1-(3-methyl-2-buten-1-yl)-6-chloro-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4(1H,3H)-dione

1-(3-methyl-2-buten-1-yl)-6-chloro-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4(1H,3H)-dione

acetaldehyde
75-07-0

acetaldehyde

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

4,4'-(2-methylpropane-1,3-diyl)bis(2-chloromethylquinazoline)

4,4'-(2-methylpropane-1,3-diyl)bis(2-chloromethylquinazoline)

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 10 - 25℃; for 17.5h;77.78%
8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

C20H17BrN6O2

C20H17BrN6O2

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione With chloro-trimethyl-silane; trimethylsilyl trifluoromethanesulfonate In toluene for 24h; Reflux;
Stage #2: 2-chloromethyl-4-methylquinazoline With sodium hydride In N,N-dimethyl-formamide at 0 - 10℃; for 5h;
72.5%
7-allyl-8-bromo-3-methyl-1H-purine-2,6(3H,7H)-dione

7-allyl-8-bromo-3-methyl-1H-purine-2,6(3H,7H)-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

7-allyl-8-bromo-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-1H-purine-2,6(3H,7H)-dione

7-allyl-8-bromo-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-1H-purine-2,6(3H,7H)-dione

Conditions
ConditionsYield
With sodium carbonate In N,N-dimethyl-formamide at 80℃; for 12h;72%
C23H22N6O4

C23H22N6O4

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione
886588-63-2

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine2,6-dione

Conditions
ConditionsYield
With potassium carbonate In tetrahydrofuran for 25h; Reflux;69.8%
1-allyl-6-chloropyrimidine-2,4(1H,3H)-dione

1-allyl-6-chloropyrimidine-2,4(1H,3H)-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

1-allyl-6-chloro-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4(1H,3H)-dione

1-allyl-6-chloro-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
Stage #1: 1-allyl-6-chloropyrimidine-2,4(1H,3H)-dione With sodium hydride; lithium bromide In N,N-dimethyl-formamide at 0℃; for 0.5h; Inert atmosphere;
Stage #2: 2-chloromethyl-4-methylquinazoline In N,N-dimethyl-formamide at 80℃; Inert atmosphere;
65%
3-(R)-aminopiperidine dihydrochloride

3-(R)-aminopiperidine dihydrochloride

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione
666816-98-4

8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,,6-dihydro-1H-purine-2,6-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

Linagliptin

Linagliptin

Conditions
ConditionsYield
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; 2-chloromethyl-4-methylquinazoline With potassium carbonate In N,N-dimethyl-formamide at 90℃; for 6h;
Stage #2: 3-(R)-aminopiperidine dihydrochloride With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 8h;
57%
Stage #1: 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione; 2-chloromethyl-4-methylquinazoline With potassium carbonate In N,N-dimethyl-formamide at 90℃; for 6h;
Stage #2: 3-(R)-aminopiperidine dihydrochloride With potassium carbonate In N,N-dimethyl-formamide at 20 - 80℃; for 8h;
Stage #3: pH=8;
57%
2,2,2-trifluoroacetamide
354-38-1

2,2,2-trifluoroacetamide

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

2,2,2-trifluoro-N-((4-methylquinazolin-2-yl)methyl)acetamide

2,2,2-trifluoro-N-((4-methylquinazolin-2-yl)methyl)acetamide

Conditions
ConditionsYield
Stage #1: 2,2,2-trifluoroacetamide With caesium carbonate In tetrahydrofuran at 20℃; for 0.0833333h; Inert atmosphere;
Stage #2: 2-chloromethyl-4-methylquinazoline In tetrahydrofuran at 65℃; for 16h; Inert atmosphere;
55%
2-[(6-chloro-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)methyl]benzonitrile
865758-95-8

2-[(6-chloro-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)methyl]benzonitrile

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

6-chloro-1-(2-cyanobenzyl)-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4(1H,3H)-dione

6-chloro-1-(2-cyanobenzyl)-3-[(4-methylquinazolin-2-yl)methyl]pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
Stage #1: 2-[(6-chloro-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)methyl]benzonitrile With sodium hydride; lithium bromide In N,N-dimethyl-formamide at 0℃; for 0.5h; Inert atmosphere;
Stage #2: 2-chloromethyl-4-methylquinazoline In N,N-dimethyl-formamide at 80℃; Inert atmosphere;
50%
2,5-dimethoxyphenylboronic acid
107099-99-0

2,5-dimethoxyphenylboronic acid

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

C18H18N2O2
1416422-98-4

C18H18N2O2

Conditions
ConditionsYield
With potassium phosphate; C12H10ClNPd*C16H21O3P In tetrahydrofuran; water at 60℃; for 20h;24%
6-chloro-1-(prop-2-ynyl)pyrimidine-2,4(1H,3H)-dione

6-chloro-1-(prop-2-ynyl)pyrimidine-2,4(1H,3H)-dione

2-chloromethyl-4-methylquinazoline
109113-72-6

2-chloromethyl-4-methylquinazoline

6-chloro-3-[(4-methylquinazolin-2-yl)methyl]-1-(prop-2-ynyl)pyrimidine-2,4(1H,3H)-dione

6-chloro-3-[(4-methylquinazolin-2-yl)methyl]-1-(prop-2-ynyl)pyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
Stage #1: 6-chloro-1-(prop-2-ynyl)pyrimidine-2,4(1H,3H)-dione With sodium hydride; lithium bromide In N,N-dimethyl-formamide at 0℃; for 0.5h; Inert atmosphere;
Stage #2: 2-chloromethyl-4-methylquinazoline In N,N-dimethyl-formamide at 80℃; Inert atmosphere;
22%

2-(Chloromethyl)-4-methylquinazoline Specification

The 2-(Chloromethyl)-4-methylquinazoline, with the CAS registry number 109113-72-6, is also known as 2-Amino-3,4-dimethylbenzoic acid. This chemical's molecular formula is C10H9ClN2 and molecular weight is 192.64. What's more, its systematic name is 2-(Chloromethyl)-4-methylquinazoline.

Physical properties of 2-(Chloromethyl)-4-methylquinazoline are: (1)ACD/LogP: 2.009; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2.01; (4)ACD/LogD (pH 7.4): 2.01; (5)ACD/BCF (pH 5.5): 19.78; (6)ACD/BCF (pH 7.4): 19.79; (7)ACD/KOC (pH 5.5): 294.75; (8)ACD/KOC (pH 7.4): 294.87; (9)#H bond acceptors: 2; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 1; (12)Polar Surface Area: 25.78 Å2; (13)Index of Refraction: 1.631; (14)Molar Refractivity: 54.868 cm3; (15)Molar Volume: 153.967 cm3; (16)Polarizability: 21.752×10-24cm3; (17)Surface Tension: 51.42 dyne/cm; (18)Density: 1.251 g/cm3; (19)Flash Point: 122.14 °C; (20)Enthalpy of Vaporization: 45.761 kJ/mol; (21)Boiling Point: 240.039 °C at 760 mmHg; (22)Vapour Pressure: 0.06 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: ClCc2nc1c(cccc1)c(n2)
(2)Std. InChI: InChI=1S/C10H9ClN2/c1-7-8-4-2-3-5-9(8)13-10(6-11)12-7/h2-5H,6H2,1H3
(3)Std. InChIKey: UHCUBOJGMLASBY-UHFFFAOYSA-N

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View